Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 1.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.00M
Minimum
Dec 2021
1.00M
Maximum
Dec 2021
1.00M
Average
1.00M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
Eli Lilly and Co | 11.44B |
Viking Therapeutics Inc | -- |
Biomarin Pharmaceutical Inc | 745.74M |
Elite Pharmaceuticals Inc | 18.88M |
Verrica Pharmaceuticals Inc | -1.781M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -21.94M |
Total Expenses (Quarterly) | 24.94M |
EPS Diluted (Quarterly) | -0.28 |
Enterprise Value | 112.22M |
Earnings Yield | -20.38% |